ESCRS - PO0804 - Post Cataract Surgery Dry Eye Disease, Effectiveness Of Semifluorinated Alkanes (Perfluorohexyloctane) Eye Drops .

Post Cataract Surgery Dry Eye Disease, Effectiveness Of Semifluorinated Alkanes (Perfluorohexyloctane) Eye Drops .

Published 2023 - 41st Congress of the ESCRS

Reference: PO0804 | Type: Free paper | DOI: 10.82333/mfzg-0388

Authors: Simone Alex Bagaglia* 1 , Angelo Balestrazzi 2

1Ophthalmology,Sant.Andrea Hospital,Massa Marittima,Italy, 2Ophthalmology,Ospedale Della Misericordia,Grosseto,Italy

Purpose

 To evaluate the effectiveness of Semifluorinated Alkanes (perfluorohexyloctane) eye drops for the treatment of post operative cataract  Dry eye disease

Setting

Massa Marittima Hospital, Department of Ophthalmology 

Methods

60 patients 30 controls 

mean age 69.8 years +- 9.4 years

 M/F ratio 1:3

Affected by dry eye disease  

INCLUSION CRITERIA: 

preoperative subjective indicating dry eye disease

OSDI TBUT and 

 EXCLUSION CRITERIA: dry eye due to systemic disease or concomitant therapy,  preoperative glaucoma therapy, use of contact lenses

Each patient was  treated with pre-operative therapy 3 days before and 28 days post-op with steroid antibiotic fixed association (0.3% Dexamethasone 0.1% netilmicin without preservatives)  3 times daily to reduce. Bromfenac Sodium Sesuqhydrate 0.9mg/ml eye drops  2 times a day .in both sample group and controls. The squid population  In addition to the therapy the therapy perfluorohexyloctane eye drops twice a day for 3 months.    

Results

TEST, OSDI, BUT, OXFORD demonstrated significant improvement at 1 and 3 months post operatively  compared to the controls 

Conclusions

PERFLUOROHEXYLOCTANE proved to be an effective molecule in reducing the symptoms of ocular discomfort in  post operative DED.